Tech Company Financing Transactions
Fenway Pharmaceuticals Funding Round
New Enterprise Associates invested in a $475 thousand venture round for Fenway Pharmaceuticals. The round was announced on 6/30/2008.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$475,000
Round
Undisclosed
Investors
New Enterprise Associates (Michael Raab)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1 Gateway Center 809
Newton, MA 02458
USA
Newton, MA 02458
USA
Phone
Email Address
Not Recorded
Overview
The company is developing pharmaceutical treatment technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Skaletsky
Browse more venture capital transactions:
Prev: 6/30/2008: Xelerated venture capital transaction
Next: 6/30/2008: BMG Seltec venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs